Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer

IF 4.3 3区 材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Daisuke Shibahara , Kentaro Tanaka , Osamu Togao , Yoshimasa Shiraishi , Yasuto Yoneshima , Eiji Iwama , Tadamasa Yoshitake , Kousei Ishigami , Isamu Okamoto
{"title":"Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer","authors":"Daisuke Shibahara ,&nbsp;Kentaro Tanaka ,&nbsp;Osamu Togao ,&nbsp;Yoshimasa Shiraishi ,&nbsp;Yasuto Yoneshima ,&nbsp;Eiji Iwama ,&nbsp;Tadamasa Yoshitake ,&nbsp;Kousei Ishigami ,&nbsp;Isamu Okamoto","doi":"10.1016/j.cllc.2024.06.010","DOIUrl":null,"url":null,"abstract":"<div><p></p><ul><li><span>•</span><span><p>The incidence of brain radiation necrosis is increasing in NSCLC patients undergoing radiotherapy for brain metastases.</p></span></li><li><span>•</span><span><p>[<sup>11</sup>C] methionine–PET and MRS are valuable tools for diagnosing brain radiation necrosis.</p></span></li><li><span>•</span><span><p>Bevacizumab is an effective treatment for brain radiation necrosis in patients with nonsquamous NSCLC.</p></span></li></ul></div>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1525730424001359/pdfft?md5=6792b8d4e751aaccaf770a85083f2252&pid=1-s2.0-S1525730424001359-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1525730424001359","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0

Abstract

  • The incidence of brain radiation necrosis is increasing in NSCLC patients undergoing radiotherapy for brain metastases.

  • [11C] methionine–PET and MRS are valuable tools for diagnosing brain radiation necrosis.

  • Bevacizumab is an effective treatment for brain radiation necrosis in patients with nonsquamous NSCLC.

贝伐单抗治疗非鳞癌非小细胞肺癌患者的脑放射坏死
-11C]蛋氨酸-PET 和 MRS 是诊断脑放射坏死的重要工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
4.30%
发文量
567
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信